Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment
2003 · Biological Psychiatry · 180 citations
https://doi.org/10.1016/s0006-3223(03)00424-4
K
Keh-Ming Lin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
1.6K
Citations
17
h-index
20
i10-index
Keh-Ming Lin is an academic researcher from National Taiwan University. The author has contributed to research in topics: Treatment of Major Depression & Pharmacogenetics and Drug Metabolism & Substance Abuse Treatment and Outcomes. The author has an h-index of 17, co-authored 23 publications.
Papers by this author
worksGenetic Polymorphisms of Cytochrome P450 Enzymes Influence Metabolism of the Antidepressant Escitalopram and Treatment Response
2010 · Pharmacogenomics · 115 citations
https://doi.org/10.2217/pgs.09.168
NEURASTHENIA, DEPRESSION AND SOMATOFORM DISORDER IN A CHINESE-VIETNAMESE WOMAN MIGRANT
1997 · Culture Medicine and Psychiatry · 21 citations
https://doi.org/10.1023/a:1005340905397
Comparison of escitalopram and paroxetine in the treatment of major depressive disorder
2013 · International Clinical Psychopharmacology · 11 citations
https://doi.org/10.1097/yic.0b013e32836458e2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat